Sales of biogenerics in US, Europe to soar-study LONDON (Reuters)

Sales of biogenerics in US, Europe to soar-study
LONDON (Reuters) - Copycat versions of expensive biotech drugs could see $16.4 billion in sales in the United States and Europe by 2011 once regulatory curbs on so-called biogenerics use are gone, a study showed on Monday.

Radiation-induced chromosomal aberrations persist
NEW YORK (Reuters Health) - Chromosomal aberrations persist for years after occupational exposure to ionizing radiation, according to a new report in the September issue of Genes, Chromosomes & Cancer.